Aurora Cannabis CEO Martin Adds Executive Chairman Role

Ticker: ACB · Form: 6-K · Filed: 2024-09-20T00:00:00.000Z

Sentiment: neutral

Topics: leadership-change, executive-appointment

TL;DR

Aurora CEO Miguel Martin is now also Executive Chairman, effective Sept 20, 2024.

AI Summary

Aurora Cannabis Inc. announced on September 20, 2024, that CEO Miguel Martin has assumed the additional role of Executive Chairman. This change follows the resignation of Michael Singer from the Executive Chairman position.

Why It Matters

This leadership change could signal a shift in strategic direction or a consolidation of power within Aurora Cannabis's executive team.

Risk Assessment

Risk Level: low — The filing is a routine report of a leadership change and does not involve significant financial transactions or operational shifts.

Key Players & Entities

FAQ

What is the effective date of Miguel Martin's new role?

Miguel Martin's appointment as Executive Chairman is effective September 20, 2024.

Who previously held the Executive Chairman position?

Michael Singer previously held the Executive Chairman position.

What is Aurora Cannabis Inc.'s principal executive office address?

Aurora Cannabis Inc.'s principal executive office is located at 2207 90B St. SW Edmonton, Alberta T6X 1V8, Canada.

What type of report is this filing?

This filing is a Form 6-K, Report of Foreign Private Issuer.

What is the SIC code for Aurora Cannabis Inc.?

The Standard Industrial Classification (SIC) code for Aurora Cannabis Inc. is 2833, Medicinal Chemicals & Botanical Products.

From the Filing

0001279569-24-001141.txt : 20240920 0001279569-24-001141.hdr.sgml : 20240920 20240920071942 ACCESSION NUMBER: 0001279569-24-001141 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20240920 FILED AS OF DATE: 20240920 DATE AS OF CHANGE: 20240920 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AURORA CANNABIS INC CENTRAL INDEX KEY: 0001683541 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38691 FILM NUMBER: 241311689 BUSINESS ADDRESS: STREET 1: 2207 90B STREET SW CITY: EDMONTON STATE: A0 ZIP: T6X 1V8 BUSINESS PHONE: 604-362-5207 MAIL ADDRESS: STREET 1: 409 GRANVILLE STREET STREET 2: SUITE 1700 CITY: VANCOUVER STATE: A1 ZIP: V6C 1T2 6-K 1 aurora_6k.htm FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2024 Commission File No. 001-38691 AURORA CANNABIS INC. (Translation of registrant's name into English) 2207 90B St. SW Edmonton, Alberta T6X 1V8 Canada (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F Form 20-F ☐ Form 40-F ☒ SUBMITTED HEREWITH Exhibits Description 99.1 News Release dated September 20, 2024 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. AURORA CANNABIS INC. /s/ Miguel Martin Miguel Martin Chief Executive Officer Date: September 20, 2024 EX-99.1 2 ex991.htm NEWS RELEASE DATED SEPTEMBER 20, 2024 Exhibit 99.1 Aurora CEO Miguel Martin takes on additional role as Executive Chairman of Board of Directors NASDAQ | TSX: ACB Outgoing Chairman Ron Funk appointed Lead Independent Director, as part of Board leadership transition EDMONTON, AB, Sept. 20, 2024 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora" ) (NASDAQ: ACB) (TSX: ACB), a leading Canada-based global medical cannabis company, today announced the appointments of CEO Miguel Martin to the additional role of Executive Chairman and outgoing Chairman Ron Funk as Lead Independent Director. Both appointments follow unanimous votes by Aurora's Board and are effective immediately. Mr. Martin has served as Chief Executive Officer and a director of the Company since September 2020 and will continue to serve as Chief Executive Officer. During this time, Mr. Martin has driven significant change within the organization, including the financial recovery of the Company and successful business transformation, all while leading with focus and integrity, and in the best interests of Aurora's shareholders. As a result, Aurora has been able to weather much of the challenges that most in the cannabis industry have and continue to face. Having worked closely with and under the mentorship of Mr. Funk, who served as Chairman of the Board of Directors (the "Board") since 2021, the two are aptly positioned to continue to effectively cultivate strong and unified Board leadership and governance as the Company enters its next stage of meaningful global growth. The Board believes that combining the CEO and Chairman roles will promote strong and consistent leadership, directional clarity, and effective and efficient decision making - all of which better position Aurora to execute on its vision for global leadership. "I am excited to take on this expanded role and equally thrilled that we will have the ongoing benefit of Ron's extensive business experience, deep institutional knowledge and meticulous Board leadership and governance expertise as Lead Independent Director," stat

View on Read The Filing